Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Subst Abuse Treat. 2019 Sep 5;106:89–96. doi: 10.1016/j.jsat.2019.09.002

Table 4:

Treatment outcomes by end-of-treatment employment status.

end-of-treatment Unemployed
n = 223 (47.8%)
end-of-treatment Employed
n = 243 (52.2%)
Estimate/SE t OR P.
Clinical outcomes within treatment
Percentage of days abstinent during treatment (Mean ± SD) 64.4 ± 29.8 74.4 ± 23.3 8.69/2.56 3.39 - .001
Percentage cocaine-negative samples during treatment (Mean ± SD) 25.1 ± 33.4 33.9 ± 37.2 - - - ns
Achieved 3 or more weeks of consecutive cocaine abstinence (N (%)) 68 (30.5) 93 (38.3) - - - ns
Longest duration abstinence during treatment (days) (Mean ± SD) 16.2 ± 19.9 22.6 ± 24.6 4.75/2.17 2.19 - .029
Retained treatment and abstinence in last week of treatment (N (%)) 55 (25.7) 74 (31.6) - - - ns
Complete abstinence during treatment (N (%)) 14 (6.5) 26 (10.9) - - - ns
Clinical outcomes at follow-up
Percentage of days abstinent at follow-up month 1 (Mean ± SD) 76.7 ± 29.8 82.3 ± 24.8 5.47/2.6 2.1 - .036
Employment at follow-up month 1 (N (%)) 43 (21.2) 224 (93.3) 3.86/31 - 47.68 .001
Percentage of days abstinent at follow-up month 3 (Mean ± SD) 80.4 ± 30.2 83.3 ± 24.7 - - - ns
Employment at follow-up month 3 (N (%)) 61 (30.3) 207 (87.3) 2.76 /.25 - 15.77 .001
Percentage of days abstinent at follow-up month 6 (Mean ± SD) 80.9 ± 29.7 82.2 ± 26.5 - - - ns
Employment at follow-up month 6 (N (%)) 90 (44.8) 188 (83.2) 1.75/.23 - 5.76 .001

The unemployed group served as reference for the analyses

SE = Standard Error; OR = Odds Ratio; ns = statistically non-significant.